Works matching IS 09509232 AND DT 2011 AND VI 30 AND IP 9

Results: 11

Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome.

Published in:

Oncogene, 2011, v. 30, n. 9, p. 1046, doi. 10.1038/onc.2010.488

By:

Henry, L A;
Johnson, D A;
Sarrió, D;
Lee, S;
Quinlan, P R;
Crook, T;
Thompson, A M;
Reis-Filho, J S;
Isacke, C M

Publication type:

Article

Genomic characterization of asymptomatic CT-detected lung cancers.

Published in:

Oncogene, 2011, v. 30, n. 9, p. 1117, doi. 10.1038/onc.2010.478

By:

Belloni, E;
Veronesi, G;
Micucci, C;
Javan, S;
Minardi, S P;
Venturini, E;
Maisonneuve, P;
Volorio, S;
Riboni, M;
Bellomi, M;
Scanagatta, P;
Taliento, G;
Pelosi, G;
Pece, S;
Spaggiari, L;
Pelicci, P G

Publication type:

Article

Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer.

Published in:

Oncogene, 2011, v. 30, n. 9, p. 1098, doi. 10.1038/onc.2010.491

By:

Patrick, B A;
Gong, X;
Jaiswal, A K

Publication type:

Article

Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells.

Published in:

Oncogene, 2011, v. 30, n. 9, p. 1009, doi. 10.1038/onc.2010.511

By:

Majeti, R

Publication type:

Article

Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death.

Published in:

Oncogene, 2011, v. 30, n. 9, p. 1127, doi. 10.1038/onc.2010.490

By:

Lui, V W Y;
Wong, E Y L;
Ho, K;
Ng, P K S;
Lau, C P Y;
Tsui, S K W;
Tsang, C-M;
Tsao, S-W;
Cheng, S H;
Ng, M H L;
Ng, Y K;
Lam, E K Y;
Hong, B;
Lo, K W;
Mok, T S K;
Chan, A T C;
Mills, G B

Publication type:

Article

P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer.

Published in:

Oncogene, 2011, v. 30, n. 9, p. 1059, doi. 10.1038/onc.2010.489

By:

Montero, J C;
Seoane, S;
Ocaña, A;
Pandiella, A

Publication type:

Article

Chemical-induced cancer incidence and underlying mechanisms in Fen1 mutant mice.

Published in:

Oncogene, 2011, v. 30, n. 9, p. 1072, doi. 10.1038/onc.2010.482

By:

Xu, H;
Zheng, L;
Dai, H;
Zhou, M;
Hua, Y;
Shen, B

Publication type:

Article

SUMO E3 ligase activity of TRIM proteins.

Published in:

Oncogene, 2011, v. 30, n. 9, p. 1108, doi. 10.1038/onc.2010.462

By:

Chu, Y;
Yang, X

Publication type:

Article

MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways.

Published in:

Oncogene, 2011, v. 30, n. 9, p. 1082, doi. 10.1038/onc.2010.487

By:

Rao, X;
Di Leva, G;
Li, M;
Fang, F;
Devlin, C;
Hartman-Frey, C;
Burow, M E;
Ivan, M;
Croce, C M;
Nephew, K P

Publication type:

Article

Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin.

Published in:

Oncogene, 2011, v. 30, n. 9, p. 1020, doi. 10.1038/onc.2010.486

By:

Cheng, J-C;
Auersperg, N;
Leung, P C K

Publication type:

Article

CdGAP is required for transforming growth factor β- and Neu/ErbB-2-induced breast cancer cell motility and invasion.

Published in:

Oncogene, 2011, v. 30, n. 9, p. 1032, doi. 10.1038/onc.2010.477

By:

He, Y;
Northey, J J;
Primeau, M;
Machado, R D;
Trembath, R;
Siegel, P M;
Lamarche-Vane, N

Publication type:

Article